These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 14992993)

  • 1. Learning and brain function in schizophrenia.
    Liberman RP
    Am J Psychiatry; 2004 Mar; 161(3):580. PubMed ID: 14992993
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution of single photon emission computerized tomography (SPECT-HMPAO) to the study of schizophrenia].
    Humbert T; Maktouf C; Surel D; Grasset G; Chabrand P
    Ann Med Psychol (Paris); 1992 Nov; 150(9):659-69. PubMed ID: 1343757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspects of stability of regional cerebral blood flow in chronic schizophrenia: an 18-year followup study.
    Cantor-Graae E; Warkentin S; Franzén G; Risberg J; Ingvar DH
    Psychiatry Res; 1991 Dec; 40(4):253-66. PubMed ID: 1811243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia, VIII: pharmacologic models.
    Lahti AC; Holcomb HH
    Am J Psychiatry; 2003 Dec; 160(12):2091. PubMed ID: 14638574
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional differentiation of cortical activity in schizophrenia: a complementary approach to conventional analysis of regional cerebral blood flow.
    Hook S; Gordon E; Lazzaro I; Burke C; Anderson J; Zurynski Y; Snars J; Meares R
    Psychiatry Res; 1995 Aug; 61(2):85-93. PubMed ID: 7480391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatch negativity: an index of a preattentive processing deficit in schizophrenia.
    Shelley AM; Ward PB; Catts SV; Michie PT; Andrews S; McConaghy N
    Biol Psychiatry; 1991 Nov; 30(10):1059-62. PubMed ID: 1756198
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology.
    Wolkin A; Sanfilipo M; Angrist B; Duncan E; Wieland S; Wolf AP; Brodie JD; Cooper TB; Laska E; Rotrosen JP
    Biol Psychiatry; 1994 Sep; 36(5):317-25. PubMed ID: 7993958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional cerebral blood flow in patients with schizophrenia. A preliminary report.
    Kawasaki Y; Suzuki M; Maeda Y; Urata K; Yamaguchi N; Matsuda H; Hisada K; Suzuki M; Takashima T
    Eur Arch Psychiatry Clin Neurosci; 1992; 241(4):195-200. PubMed ID: 1576174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of regional cerebral blood flow with performance on neuropsychological tests in schizophrenic patients.
    Sagawa K; Kawakatsu S; Shibuya I; Oiji A; Morinobu S; Komatani A; Yazaki M; Totsuka S
    Schizophr Res; 1990; 3(4):241-6. PubMed ID: 2278985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological cerebral blood blow and corpus callosum abnormalities in schizophrenia: relations to EEG mapping and PET data.
    Guenther W; Moser E; Petsch R; Brodie JD; Steinberg R; Streck P
    Psychiatry Res; 1989 Sep; 29(3):453-5. PubMed ID: 2608818
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormalities of the septum pellucidum in schizophrenia.
    Luauté JP; Sanabria E; Bauge JP; Rodde B
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):461-2. PubMed ID: 2136400
    [No Abstract]   [Full Text] [Related]  

  • 12. Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET).
    Kaplan RD; Szechtman H; Franco S; Szechtman B; Nahmias C; Garnett ES; List S; Cleghorn JM
    Schizophr Res; 1993 Dec; 11(1):47-54. PubMed ID: 8297804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral blood flow activation and functional lesions in schizophrenia.
    Taylor SF
    Schizophr Res; 1996 May; 19(2-3):129-40. PubMed ID: 8789911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
    Potkin SG; Alva G; Fleming K; Anand R; Keator D; Carreon D; Doo M; Jin Y; Wu JC; Fallon JH
    Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia.
    Busatto GF; Pilowsky LS; Costa DC; Ell PJ; David AS; Lucey JV; Kerwin RW
    Am J Psychiatry; 1997 Jan; 154(1):56-63. PubMed ID: 8988959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics.
    Sabri O; Erkwoh R; Schreckenberger M; Owega A; Sass H; Buell U
    Lancet; 1997 Jun; 349(9067):1735-9. PubMed ID: 9193384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional correlates of subsyndromes in chronic schizophrenia.
    Schröder J; Buchsbaum MS; Siegel BV; Geider FJ; Niethammer R
    Psychopathology; 1995; 28(1):38-45. PubMed ID: 7871119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between regional cerebral blood flow and the Wisconsin Card Sorting Test in negative schizophrenia.
    Liu Z; Tam WC; Xie Y; Zhao J
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):3-7. PubMed ID: 11929565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between delta activity during all-night sleep and negative symptoms in schizophrenia: a preliminary study.
    Kajimura N; Kato M; Okuma T; Sekimoto M; Watanabe T; Takahashi K
    Biol Psychiatry; 1996 Mar; 39(6):451-4. PubMed ID: 8679792
    [No Abstract]   [Full Text] [Related]  

  • 20. Toward a brain map of auditory hallucinations.
    Cleghorn JM; Franco S; Szechtman B; Kaplan RD; Szechtman H; Brown GM; Nahmias C; Garnett ES
    Am J Psychiatry; 1992 Aug; 149(8):1062-9. PubMed ID: 1353314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.